FALLOPIAN TUBE CANCERS
Clinical trials for FALLOPIAN TUBE CANCERS explained in plain language.
Never miss a new study
Get alerted when new FALLOPIAN TUBE CANCERS trials appear
Sign up with your email to follow new studies for FALLOPIAN TUBE CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for Hard-to-Treat ovarian cancer
Disease control Recruiting nowThis study tests a drug called mirvetuximab soravtansine (MIRV) in people with a type of ovarian cancer that no longer responds to platinum chemotherapy. The drug targets a protein called FRα on cancer cells to deliver a cell-killing agent. About 110 participants will receive MIR…
Matched conditions: FALLOPIAN TUBE CANCERS
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC
-
New drug combo aims to shrink ovarian tumors before surgery
Disease control Recruiting nowThis study tests whether adding a new drug called TORL-1-23 to standard chemotherapy before surgery can help women with advanced ovarian cancer. About 60 participants with a specific tumor marker (CLDN6) will receive the combination, then have surgery to remove remaining cancer. …
Matched conditions: FALLOPIAN TUBE CANCERS
Phase: PHASE1, PHASE2 • Sponsor: TORL Biotherapeutics, LLC • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC